Generic Drugs to Hit Market Faster with FDA Patent Form Change

June 26, 2019

Generic drug makers such as Teva Pharmaceutical Industries and Mylan Pharmaceuticals could get their lower-cost drugs on the market faster under a change to the Food and Drug Administration’s (FDA) patent certification program.

Related Stories